Navigation Links
Dragon announces new product launch; increase in annual production output capacity
Date:3/5/2008

inst Gram-positive and Gram-negative bacteria. Since Ceftazidime is effective against bacteria resistant to Ampicillin and other cephalosporin drugs, the demand in Chinese market has been increasing dramatically, with an average annual growth rate of 200% in the past few years. The Company's production output of Ceftazidime in crude powder form is projected to be 100 tons in 2008 and most of the product will be supplied to a long-term customer.

The Company has also introduced Cefalexin into its product portfolio. Cefalexin is a first-generation cephalosporin antibiotic but its chemical composition makes it effective in treatment of patients that show sensitivity to penicillin drugs. Cefalexin is widely used to treat urinary tract infections, respiratory tract infections, skin and soft tissue infections.

In support of strategies to expand Dragon's market share for antibiotic formulation products in Chinese market, the Company is also pleased to announce the appointment of Mr. Yimin Guo as the Vice President of Sales and Marketing for Shanxi Weiqida Pharmaceutical Ltd, a wholly-owned subsidiary of Dragon Pharma. Mr. Guo will oversee all sales and marketing activities in both Chinese and international markets. Mr. Guo has over 20 years of extensive sales and marketing experience and expertise in antibiotic drugs industry in China. Prior to joining Dragon, Mr. Guo served as the Sales Director at Harbin Pharmaceutical Group, the largest producer of antibiotic drugs in China. "We are very pleased to have Yimin joining our executive management team," said Dragon Chairman and CEO Mr. Yanlin Han. "Yimin's expertise in sales and marketing, coupled with his depth of knowledge in the Chinese antibiotic industry, will be invaluable to Dragon and will further bolster our strong sales and marketing division. Dragon is experiencing rapid growth and we are pursuing the goal of becoming a leading vertically integrated antibiotic drugs manufacturer. We believe that Yimin
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dragon Announces R&D Achievement in Biotech Manufacturing Process
2. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
3. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
4. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
5. China Yingxia International Announces Q4 and FY 2007 Estimates
6. Bristol-Myers Squibb Announces Dividend
7. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
8. Maxygen Announces Management Changes
9. Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility
10. Exanet Announces ExaStore 2008 Clustered NAS System
11. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Decision Resources Group finds that the ... 12 percent compound annual growth rate through 2023. This ... and the increasing adoption of dental implants. Growing aesthetic ... also spur demand for dental biomaterials because they can ... treatments. Other key findings from Decision Resources ...
(Date:12/19/2014)... 2014 Today, TiFiber, Inc. ... production facility and future company headquarters in Fort ... new materials that safely and effectively control dangerous ... of its historic, strong support for manufacturing, but ... leading edge, technology-based companies such as TiFiber. ...
(Date:12/19/2014)... 18, 2014 Reports from CDC ... States suffer from one or more chronic health conditions ... Medication can address some of these diseases, but may ... many sufferers face. While implanted nerve stimulation devices today ... whole nerve, which can induce side effects. , ...
(Date:12/19/2014)... December 19, 2014 The empty ... the rising ageing population and technological innovations in ... nutraceutical industries are catalysing the growth of the ... http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report , ... well as new entrants/smaller firms to gauge the ...
Breaking Biology Technology:Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4
... Experts ... Life Sciences industry , ... Wayne, PA (PRWEB) February 2, 2010 -- MODA Technology Partners, a global ... industry, today announced four new members to its product advisory board focused on improving ...
... EXTON, Pa. , Feb. 2 ... company focused on the development of regenerative cell therapy ... David Pernock , Chairman of the Board of ... immediately. Pernock most recently served as Senior Vice President ...
... , SANTA ROSA, Calif. , ... EcoNugenics introduces the newest in their scientifically ... Rosa, CA -based nutraceutical company, founded in 1995 by integrative medicine pioneer, ... has once again demonstrated excellence in being at the forefront of the ...
Cached Biology Technology:MODA Names New Members to QC Micro Advisory Board 2Fibrocell Science, Inc. Names David Pernock Chief Executive Officer 2Fibrocell Science, Inc. Names David Pernock Chief Executive Officer 3Just in Time for Heart Health Month... TRIPLE Cardiovascular Health Support From EcoNugenics 2Just in Time for Heart Health Month... TRIPLE Cardiovascular Health Support From EcoNugenics 3
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the leading ... study that pinpoints fine-scale differences in genetic ancestry of ... . Since immigrants first arrived more than ... has served as a meeting place for ... history and the ongoing mixing of peoples with African, ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Practices (GCP) audit to confirm its adherence to ... This accomplishment enables HITLAB to conduct regulated smart ... highest principles for patient safety and research quality. ... healthcare access, quality, and delivery with innovative technology," ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... can sustain increasing world-wide demand for at least a ... most important restrictions on future copper production. Researchers ... robust compilation and analysis of worldwide copper resources to ... important metal would run out in around 30 years, ...
... potential new antibiotic which could help in the battle ... antibiotic targets a bacterial enzyme critical to metabolic processes. ... to the enzyme (called biotin protein ligase), stopping its ... "Existing antibiotics target the bacterial cell membranes but ...
... bacteria that form the base of the ocean,s food ... new study. In climate change, as in everything, ... levels and temperature rise globally, scientists increasingly want to ... in the environment of tomorrow. The answer to ...
Cached Biology News:After millennia of mining, copper nowhere near 'peak' 2Novel chemistry for new class of antibiotic 2Greenhouse gas likely altering ocean foodchain 2